What about insulin as an immediate first step for type 2 diabetes?

Diabetes, Obesity and Metabolism

Volumn 11, Issue SUPPL. 5, 2009, Pages 19-22

  Rolla, A R ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN ASPART; ISOPHANE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TRIACYLGLYCEROL;

BEDTIME DOSAGE; BODY MASS; CLINICAL TRIAL; CONTINUOUS INFUSION; DIET RESTRICTION; DISEASE DURATION; DRUG DOSE INCREASE; DRUG EFFICACY; EXERCISE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INDIVIDUALIZATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; REMISSION; REVIEW; TREATMENT OUTCOME;

BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; TIME FACTORS;

EID: 70350278566     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01140.x     Document Type: Review

References (11)

1. Standards of medical care in diabetes-2009. Diabetes Care 2009, 32:S13-S61. American Diabetes Association, (Suppl. 1)
2. Li Y, Xu W, Liao Z. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 2004, 27:2597-2602.
3. Weng J, Li Y, Xu W. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 2008, 371:1753-1760.
4. Chen H, Wu TE, Jap TS. Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy. Diabetes Care 2008, 31:1927-1932.
5. Lingvay I, Kaloyanova PF, Adams-Huet B. Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted. J Investig Med 2007, 55:62-68.
6. Ryan EA, Imes S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 2004, 27:1028-1032.
7. Park S, Choi SB. Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy. Diabetes Metab Res Rev 2003, 19:124-130.
8. Hidaka H, Nagulesparan M, Klimes I. Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. J Clin Endocrinol Metab 1982, 54:217-222.
9. Yki-Järvinen H, Esko N, Eero H. Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 1988, 84:185-192.
10. Garvey WT, Revers RR, Kolterman OG. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus. J Clin Endocrinol Metab 1985, 60:559-568.
11. Gormley MJ, Hadden DR, Woods R. One month's insulin treatment of type II diabetes: the early and medium-term effects following insulin withdrawal. Metabolism 1986, 35:1029-1036.